
    
      The investigators hypothesize that the gummy and tablet preparations of vitamin D3 supplement
      will be biologically equivalent, as defined by the absence of a statistically significant
      difference in bioavailability measured as blood levels of vitamin D3 after administration of
      the same dose of gummy and tablet supplementation.
    
  